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Ex Vivo Model of Cerebrospinal Fluid Outflow across
Human Arachnoid Granulations
Shelley A. Glimcher,1,2 David W. Holman,1,2 Martin Lubow,2 and
Deborah M. Grzybowski1,2
PURPOSE. The brain’s arachnoid membrane with granulations is
an important biological barrier whose responsibilities include
the transmission of cerebrospinal fluid (CSF) and the regulation
of pressure. Membrane disturbance may cause changes that are
difficult to replicate with animal models, suggesting the need
for a model using human arachnoid membrane with granula-
tions for the study of conditions such as Alzheimer disease,
hydrocephalus, and pseudotumor cerebri. The authors detail
the development and validation of an ex vivo model of CSF
outflow across human arachnoid granulations (AGs) as an ap-
proximation of in vivo conditions.
METHODS. Human AGs were perfused at normal physiological
pressure in physiological and nonphysiological directions for
permeability data. Fluorescent particle perfusion with electron
microscopy identified outflow pathways through the AGs.
RESULTS. This human ex vivo model demonstrated in vivo
properties of unidirectionality, particle transport, and ultra-
structure, similar to our 2005 in vitro model. The average
baseline hydraulic conductivity in the physiological direction
(n  20) was 1.05  0.15 L/min/mm Hg/cm2 compared with
0.11  0.03 L/min/mm Hg/cm2 in the nonphysiological di-
rection (n  3) under statistically equivalent (P  0.46) aver-
age normal physiological pressures (5.88  0.22 mm Hg and
6.14  0.23 mm Hg, respectively).
CONCLUSIONS. The ex vivo model is feasible and herein demon-
strated. These findings agree with in vivo CSF outflow. This
model increases understanding of the clearance not only of CSF
but also of metabolites through the arachnoid membrane. Ad-
ditional evidence suggests, but does not yet prove, that CSF
outflow may occur in a similar manner in the arachnoid mem-
brane adjacent to the granulations, in addition to the flow
through the AGs. This is a topic for further investigation.
(Invest Ophthalmol Vis Sci. 2008;49:4721–4728) DOI:
10.1167/iovs.08-2238
Blood-cerebrospinal fluid (CSF) barriers are composed of thechoroid plexus (CP) epithelium and the arachnoid mem-
brane.1,2 The first is responsible for cerebrospinal fluid (CSF)
formation and secretion, whereas the latter interface, along
with probable but undefined contributions from the extracra-
nial lymphatics, is responsible for CSF absorption.1,3–19 Al-
though extensive information is available on human CP epithe-
lium, knowledge of fluid transport across the arachnoid
membrane, from the subarachnoid space to the venous system,
remains limited.
Researchers have performed ex vivo perfusion experi-
ments on animals,20 –24 but no previous studies developed
an ex vivo perfusion model of human arachnoid granulations
(AGs). Although AGs in humans are similar to those of other
species, there are important differences such that animal
models are not adequately representative of human physiol-
ogy.13,25–27 Of note are the visible AG structures, suggested
to be herniations of the arachnoid membrane, described by
Kida et al.26 In the development of this ex vivo model, the
term human arachnoid membrane refers to samples that
contain these visible AGs.
There are other advantages of the ex vivo model over animal
and in vitro studies. Earlier animal studies exposed the combined
arachnoid membrane and dura to nonphysiological pressure,
causing a potentially nonphysiological response.23,28,29 Notably,
our ex vivo model maintains a physiological pressure gradient
across human AGs for the duration of the experiment. We have
previously validated a unidirectional in vitro model of CSF
outflow through human arachnoidal cells.30 The in vitro
model, however, examined only the mesothelial arachnoidal
cells believed to be associated with fluid flow. In contrast, a
developed ex vivo model permits measurements incorporating
the physiological interaction of the components of the com-
plete membrane. These interactions might be crucial to under-
standing of the AGs in a variety of conditions, making the ex
vivo model a next logical step for understanding CSF hydrody-
namics. Important in verifying the ex vivo model is showing
the in vivo unidirectional properties previously seen in the in
vitro model.
With the use of animal models, researchers demonstrated
particle transport across the arachnoid membrane. Of par-
ticular interest, studies with monkey arachnoid membrane
showed the passage of particles and cells from 0.2 to 8 m.
23 In ultrastructural studies of the human arachnoid mem-
brane, red blood cells have been identified in extracellular
spaces. Given these earlier findings, it is important to ex-
plore the properties of particle transport across the AGs in
the ex vivo model.
This article describes the development and validation of an
ex vivo model of CSF outflow across human AGs and mem-
brane. Histologic studies were used to confirm dissection tech-
niques and to explore limitations of membrane viability. Ob-
servations of particle passage, as seen in previous animal
studies, were replicated. Particle distribution in fluid outflow
pathways was studied. Experiments under simulated normal
pressure examined the maintenance of the unidirectional prop-
erty shown in vivo and for baseline permeability data. In
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addition, we established an imaging technique to quantify




Experiments were conducted in accordance with guidelines and reg-
ulations set forth by the Office of Responsible Research Practices
Institutional Review Board for human subjects at The Ohio State
University (IRB Protocol 2002H0318) and The Declaration of Helsinki.
Human tissue samples (n  28; subject age range, 23–91) were col-
lected within 24 hours of death. Samples were collected only from
subjects free of infectious disease, advanced neurologic or hydrody-
namic disorders, subarachnoid hemorrhage, and brain tumors. Arach-
noid membrane and underlying cortex were dissected from the areas
adjacent to the longitudinal fissure. Samples were stored in sterile
Dulbecco modified Eagle medium/Ham F-12 nutrient medium (50:50
vol/vol) (Cellgro Mediatech, Herndon, VA) supplemented with L-glu-
tamine (Cellgro Mediatech), 10% newborn calf serum (Invitrogen
Gibco, Carlsbad, CA), and penicillin, streptomycin, and amphotericin B
(all Cellgro Mediatech) and were stored at 20°C until final dissection
and perfusion. All samples were perfused within 24 hours of death.
Perfusion Experiments
AGs and adjacent membrane were removed from cortical tissue,
trimmed to 5- to 6-mm diameter, and secured in a modified Ussing
chamber (model CHM4; World Precision Intruments, Inc., Sarasota, FL)
with a 4-mm O-ring. A controlled pressure gradient was maintained
across the arachnoid membrane in the physiological basal-to-apical
(B3A) or apical-to-basal (A3B) direction using the same media and
was maintained in the selected perfusion direction. The apparatus was
incubated and thermally equilibrated. An in-line pressure transducer
(Transpac IV; Abbott Critical Care Systems, North Chicago, IL) contin-
uously monitored the pressure, as described elsewhere.30 LabView
(version 6.1; National Instruments, Austin, TX) was used for transducer
data collection.30 Pressure gradients (5 mm Hg) were maintained by
adjusting the fluid reservoir height relative to the membrane in the
chamber, simulating normal in vivo pressures. Ambient pressure was
monitored to correct for atmospheric pressure changes throughout all
experiments. Perfusate was collected and measured at the conclusion and
was used to calculate an evaporation correction factor, as previously
described.30
Microparticles
FITC-conjugated polystyrene microparticles suspended in PBS (0.002–
0.0002% vol/vol; particle size 0.1, 0.2, 0.5, 1.0, and 2.0 m; Molecular
Probes, Eugene, OR) were introduced to the media upstream of the
AGs. The microparticle solution was allowed to perfuse across the AGs
for 40 to 45 minutes before fixation. Perfusate containing micropar-
ticles was sampled and qualitatively examined using an inverted mi-
croscope (Axiocam; Carl Zeiss Meditec, Inc., Dublin, CA) equipped
with DAPI, FITC, and Cy3 filter sets or was quantitatively analyzed
(Zetasizer Nanoseries ZS; Malvern Instruments, Worcestershire, UK) by
a particle counter with commercial software (Novell; Dispersion Tech-
nology; Waltham, MA).
Membrane Viability Protocol
Sample viability was assessed by staining membrane from the same
donor with a viability/cytoxicity kit (Live/Dead; Molecular Probes).
Whole pieces of AG and membrane were submerged in the viability/
cytoxicity solution (Live/Dead; Molecular Probes) for 45 minutes at
37°C. AG samples were mounted on slides and viewed under an
inverted microscope equipped with DAPI, FITC, and Cy3 filter sets.
Postperfusion Morphologic Imaging
En face images of perfused, fixed membrane were taken for surface
area quantification of visible AGs using a 35-mm camera (FM2; Nikon)
with a 55-mm, 1:2.8 lens (MicroNIKKOR; Nikon) stabilized and fo-
cused at a fixed distance. Two images were taken of the membrane in
the chamber. The film (35-mm 100 ASA Elite Chrome; Kodak, Roch-
ester, NY) was processed and scanned on a 35-mm slide scanner
(Sprintscan 4000; Polaroid). Pixel resolution was approximately 60
m, suggesting an individual AG would be approximately 5 pixels in
diameter.13 Two investigators independently used Adobe Photoshop to
manually identify the visible AGs (Fig. 1). The AG surface area was
calculated as a percentage of total area available for outflow by count-
ing the number of positive pixels in the image compared with the total
perfused area. Linear regression was used to assess reproducibility
between investigators.
Postperfusion Arachnoid Membrane Analysis
Membrane was fixed under pressure with 10% neutral-buffered forma-
lin (Richard Allen Scientific, Kalamazoo, MI), staged with ethanol and
xylene (Fisher Scientific, Pittsburgh, PA) dehydration, and embedded
FIGURE 1. Top: image of AGs inserted in perfusion chamber. Bottom:
processed image of marked (located) visible AGs.
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in paraffin. Paraffin blocks were sectioned (6–10 m) and stained with
hematoxylin and eosin (Sigma, St. Louis, MO).
For frozen sections, membrane was fixed with 4% paraformalde-
hyde and infiltrated with 20% sucrose (Sigma) solution overnight, then
embedded in OCT compound (Miles Inc., Elkhart, IN) and snap frozen
in liquid nitrogen. Frozen sample blocks were stored at 80°C until
sectioning with a cryostat (7–10 m; Bright Instrument Company Ltd.,
Huntington, UK) for immunohistochemical staining.
Slides were dried for 30 minutes, fixed for 5 minutes with iced
acetone, dried for 30 minutes, rinsed with PBS, and blocked with 10%
newborn calf serum in PBS for 30 minutes. Sections were incubated
with FITC-conjugated mouse anti–ZO-1 antibody (1:100; Zymed, South
San Francisco, CA) or Alexa Fluor 555 phalloidin (1:400; Molecular
Probes) in PBS for 1 hour, rinsed with PBS, and dried completely.
Sections were counterstained with 4,6-diamino-2-phenylindole
(DAPI), mounted with an antifade reagent (Prolong Gold with DAPI;
Invitrogen), and visualized using an inverted microscope equipped
with DAPI, FITC, and Cy3 filter sets. Negative controls were processed
using the same protocol but with the primary antibody omitted.
Electron Microscopy
For transmission electron microscopy (TEM) processing, membrane
was fixed with 3% glutaraldehyde (Sigma) and placed in 0.1 M phos-
phate buffer solution for 45 minutes in 3% glutaraldehyde (Sigma) in
0.1 M cacodylate buffer with 0.1% ruthenium red (SPI Supplies, West
Chester, PA) for 2 hours, followed by three buffer (0.1 M phosphate
with 0.1 M sucrose, pH 7.4) rinses for 5 minutes each. Secondary
fixation was completed with 1% osmium tetroxide (Sigma) in 0.1 M
phosphate buffer (pH 7.4) containing 0.1 M sucrose for 1 hour. The
sample was then rinsed, stained (2% uranyl acetate for 1 hour), and
dehydrated in a graded series of ethanols. Samples were incubated in
propylene oxide for 15 minutes, infiltrated with Spurr resin sand over
several hours, placed in two changes of 100% Spurr resin, and embed-
ded in Spurr resin and polymerized at 60°C overnight. Embedded
membrane was sectioned with an ultramicrotome (EM UC6; Leica,
Wetzlar, Germany) at 70 nm. Sections were placed on 100-mesh
Formvar-coated grids stained with 2% uranyl acetate and Reynolds lead
citrate and were examined under a transmission electron microscope
(G2 Bio TWIN; FEI Tecnai, Hillsboro, OR) at 80 kV.
Hydraulic Conductivity Calculations
Hydraulic conductivity (Lp) is a measure of the amount of fluid that
passes across the membrane; it depends on the surface area (A),
volumetric flow rate (Q), and pressure gradient (P). The equation
used to calculate Lp in these perfusion experiments was Lp  Q/(AP).
Statistical Analysis
One-sided Student’s t-test was performed in the analysis of the results;
P  0.001 was considered significant. Fisher Z-transformation analysis
was used to examine the correlation coefficient between independent
investigators in the developed image quantification technique.
RESULTS
Feasibility Studies: Histology and Transmission
Electron Microscopy
Hematoxylin and eosin (H&E)–stained paraffin-embedded
membrane sections permitted examination of the membrane
morphology. Images confirmed the removal of all cortical tis-
sue, leaving only the arachnoid membrane with granulations. A
typical AG is seen in Figure 2, with arachnoidal cells around the
outer surface and more predominantly at the apex of the
granulation. These cells were also found dispersed throughout
the collagenous fibrous capsule, lining the apical side of the
AG, and clustered at the cap cell area of the AG.
Preliminary viability/cytoxicity (Live/Dead; Molecular
Probes) stains of perfused AG samples confirmed viability of
the membrane up to 24 after death. AGs stained immediately
after collection showed viability, whereas postperfusion AGs
exhibited no viability 24 hours after death.
Frozen sections of perfused AGs were immunohistochemi-
cally stained for ZO-1 and fluorescence microscopy. These
sections stained positively for ZO-1 (Fig. 3, arrows) indicating
tight junctions in the membrane after perfusion. The Figure 3
inset shows ZO-1 staining around a nucleus, indicating numer-
ous tight junctions. A negative control for ZO-1 appropriately
did not stain, confirming the specificity of the ZO-1 antibody
(results not shown).
TEM images of physiologically oriented, perfused AGs
showed features consistent with those described in earlier
morphologic studies, including intracellular vacuoles, extracel-
lular cisterns, desmosomal cell-to-cell junctions, and pinocy-
totic vesicles.13,16,25,32 Figure 4 shows extracellular cisterns
ranging from 1 to 4 m in diameter. Additionally, an extended
extracellular cistern was seen at the apical edge of the perfused
AG. Optically empty spaces not clearly enclosed by an intact
cellular membrane were classified as cisterns; some had des-
mosomal junctions at either end. Figure 5 shows an intracellu-
FIGURE 2. H&E staining of paraffin-embedded AG. Arrow: cluster of
arachnoid cells near the apex.
FIGURE 3. Fluorescence staining of ZO-1 in AG after perfusion in
physiological direction (arrow). Inset: enlargement of stained cell
border.
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lar vacuole in a position of exocytosis (arrow) from the apical
side of the AG. In addition, this same image shows the pres-
ence of numerous intracellular vacuoles throughout the arach-
noidal cells, consistent with pinocytotic activity. Figure 6
shows postperfusion AGs with numerous desmosomal cell-cell
junctions characteristic of cells of arachnoidal origin.
Microparticle Transport Results
Preliminary physiological basal-to-apical (B3A) perfusion ex-
periments showed the presence of 0.5-m particles in the
perfusate when examined by fluorescence microscopy (data
not shown). This result was replicated with multisized micro-
particles (0.1–2.0 m), and passage was confirmed but not
quantified by visual comparison to the microparticle stock
solution using fluorescence microscopy (data not shown).
Light-scattering analysis of experimental perfusate examined
the presence of particles in the solution and confirmed the
passage of 0.5- and 2.0-m particles across the arachnoid mem-
brane by light-intensity data. The first intensity peak in Figure
7 at 460 nm and the second peak at 2497 nm corresponded to
0.5- and 2.0-m particles in the perfusate. The difference from
the expected particle size and the obtained light-intensity peak
might be attributed to the presence of a hydrated radius sur-
rounding the suspended particles. Additionally, light-scattering
analysis enabled particle counts, revealing a ratio of 99:1 of 0.5-
to 2.0-m particles in the perfusate solution. The ratio of 0.5-
to 2.0-m particles in the original suspension introduced to the
system was 64:1.
In conjunction with histologic techniques, microparticle
location helped to determine fluid outflow pathways. In phys-
iologically perfused AGs, microparticles were located on the
basal side of the AG, within the stem (arrow), core capsule
(arrow), and cap cell regions (arrow) of AGs. Figure 8 shows an
AG with microparticles in the central core and at the apical
edge and cap cell cluster.
With nonphysiologically perfused (A3B) arachnoid mem-
brane, the perfusate did not contain microparticles (data not
shown). Figure 9 shows the location of particles in such AGs.
Compared with physiologically perfused AGs, microparticles
in AGs did not penetrate the AG. In addition, the AGs appeared
crushed rather than distended, as in Figure 8, suggesting mem-
brane damage.
Fluid Directionality Perfusion Experiment Results
Human AGs were perfused at normal (physiological) pressure
with the AGs oriented physiologically (B3A) or nonphysi-
ologically (A3B). A summary of the average pressure drop
across the AGs, average volumetric flow rate, and average
hydraulic conductivity is provided in Table 1. The average
pressure drop across the AG samples was statistically equiva-
lent regardless of AG orientation during the perfusion experi-
ment. Nevertheless, the resultant flow rate and average hydrau-
lic conductivity were significantly different.
FIGURE 4. TEM of AG after physiologic perfusion (arrow shows per-
fusion direction), showing extracellular spaces indicative of vacuoles
(stars).
FIGURE 5. TEM of AG after physiologic perfusion (arrow shows per-
fusion direction) with a vacuole opening at the apical surface (star).
FIGURE 6. TEM of AG after physiologic perfusion with desmosomes
(arrow).
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Visible AG Surface Area
To show the applicability of the technique, physiologically
perfused AG surface area (n  10) was quantified using a
modification of the imaging technique previously described.33
Figure 1 shows an image of perfused membrane and an Adobe
Photoshop rendering of the location of the visible AGs. The
identification of AGs was completed by two independent re-
searchers with an agreement of the location of AGs of r2 
0.82, indicating reproducibility. The average area of perfused
visible AGs calculated was 0.02082 cm2 (range, 0.0104–0.0358
cm2), corresponding to an average total AG area available for
outflow of 16.9%, assuming that fluid flow occurs only through
the visible AGs as is classically reported. For paired experi-
ments, adjacent AG sections with similar morphologic appear-
ance were perfused.
DISCUSSION
A successful ex vivo model needs a viable, intact, isolated AG
segment. This was confirmed by staining and viability tests for
up to, but not beyond, 24 hours.
ZO proteins are peripheral membrane proteins associated
with tight junctions in the blood-brain barrier, where they help
anchor the actin cytoskeleton.34 Cultured AG cells have dem-
onstrated positive immunohistological staining of ZO-1.31 Pos-
itive immunohistologic staining of tight junction components
for ZO-1 (Fig. 3) in postperfusion ex vivo AGs showed main-
tenance of intrinsic properties essential for regulating fluid
flow in vivo.25,34
In arachnoid membrane, desmosomal cell-to-cell junctions
serve as anchoring sites for the intermediate filament vimen-
tin.36 Desmosomes work to hold adjacent cell membranes
together, increasing the tensile strength of the cell layer
FIGURE 7. Light-scattering analysis
of perfusate after physiological per-
fusion of AGs. First light-intensity
peak (larger) corresponds to 0.5-m
particles, whereas the second light-
intensity peak corresponds to 2.0-m
particles.
FIGURE 8. Fluorescence image of 7- to 10-m frozen section, stained
(blue) nuclei after physiological perfusion (arrow) showing FITC par-
ticles in the stem, core, and apex of the AG.
FIGURE 9. Fluorescence image of stained frozen section (7–10 m).
Blue: DAPI. Red: actin. Autofluorescence in FITC range from tissue.
Particles are FITC dyed. Arrows: particles trapped at apical surface and
direction of flow.
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through the intermediate filaments they anchor and, in turn,
the strength of the membrane.37 As seen in Figure 6, desmo-
somes were identified based on their distinct morphology. The
presence of desmosomes provides support for the mainte-
nance of AG and arachnoid membrane integrity throughout the
experiment. In combination with ZO-1 fluorescence staining,
the presence of cell-cell junctions strongly suggests evidence
for the preservation of AG and membrane integrity.
Previous studies have used TEM to examine arachnoid
membrane and AG ultrastructure of animal and human tissue,
leading to proposals of multiple fluid outflow mechanisms.18,25
TEM studies by Yamashima et al.25 of human arachnoid mem-
brane showed the presence of large extracellular cisterns,
micropinocytotic vesicles, and intracellular vacuoles in the
arachnoid cell layer suggesting dual mechanisms of CSF trans-
port (transcellular and paracellular). TEM analysis of perfused
human arachnoid membrane suggests the presence of ultra-
structural features, in agreement with observations by Ya-
mashima et al.25 in whole tissue and in cells cultured from
human AG membrane.31 Large optically empty spaces in Figure
4 may correspond to extracellular cisterns associated with the
paracellular transport pathway. A fused vacuole leaving the
apical side of the arachnoid membrane and the numerous
intracellular vacuoles (Fig. 5) illustrate evidence for a transcel-
lular mechanism of CSF transport. Together these characteris-
tics are consistent with previous ultrastructural studies propos-
ing a dual transport mechanism for CSF outflow while also
demonstrating that the perfused membrane maintains intrinsic
fluid transport pathways.
A limiting factor for TEM with the ex vivo model is fresh
tissue, requiring a maximum of 12 hours from death to TEM
processing. Despite prompt processing, tissue necrosis can be
identified in TEM images. The necrosis is mainly limited to cell
organelles, and the extent is similar between different samples
processed within the 12-hour time frame. However, the critical
intact cell membrane remains, allowing for classification of
cellular ultrastructural features using TEM.
The ex vivo model permits fixation of the AGs under a
constant physiological pressure gradient. This is difficult to
accomplish in situ. Previous studies demonstrated the need for
a positive CSF pressure gradient for flow across secured
AGs.19,38,39 Our results of AG viability, integrity, and ultrastruc-
tural evidence verify that an ex vivo model of CSF outflow
across human AGs is feasible.
Animal studies have used microparticles as tracers of phys-
iological flow across the arachnoid membrane and granula-
tions, as described earlier.17,20,22,23,40,41 In our study, the pas-
sage across the AGs of FITC-conjugated microparticles (0.1–2.0
m) agrees with those previous results and indicates that AG
transport mechanisms remained intact throughout the experi-
ment. Additionally, perfusate of nonphysiologically perfused
AGs did not contain microparticles, supporting the important
unidirectional fluid flow requirement for an AG transport sys-
tem that mimics in vivo functionality.
In our ex vivo model, quantitative light-scattering analysis of
the perfusate supported particle passage and demonstrated a
technique that may be used to further analyze particle distri-
bution passed under variable conditions. These perfusate anal-
yses will be useful in future studies. Previous work by Davson
et al.42 showed that alterations in the colloidal osmotic pres-
sure of CSF did not alter the rate of absorption at the arachnoid
membrane so that the addition of microparticles to the perfus-
ate solution should not alter intrinsic transport mechanisms
across the membrane in the ex vivo model.
Intra-AG distribution and location of microparticles allowed
for additional investigation of membrane morphology and of
fluid flow pathways through AGs. Figure 8 shows more parti-
cles at the arachnoid cap cell cluster at the apex rather than at
other places in the AG, suggesting that this AG region is an
important locus along the CSF outflow pathway. This is con-
sistent with previous observations regarding fluid transport
across the arachnoid membrane.
Particles were not distributed through nonphysiologically
perfused AGs (Fig. 9). They appeared trapped on the nonphysi-
ologically pressurized apical side of the AG. The AG was not
distended but was compressed. These findings add support for
unidirectional fluid transport through the ex vivo AG model.
Microparticle experiments indicated the passage of multisized
particles, in agreement with previous research, and offer evi-
dence to confirm the unidirectional passage of fluid through
AGs.
In healthy adult humans, the pressure drop of 3 to 5 mm Hg
between the subarachnoid space and venous sinuses provides
the driving force for CSF outflow across the arachnoid mem-
brane to the venous drainage system in a basal-to-apical direc-
tion.43,44 In cases of increased venous pressure with blocked
CSF outflow, blood did not flow back into the subarachnoid
CSF. This finding supported the concept of an intrinsic unidi-
rectional property of the membrane.
To examine unidirectional properties of the ex vivo model,
the AGs were perfused in the physiological (B3A) and non-
physiological (A3B) directions. Analysis showed that for ex-
periments performed at normal pressure, a significant differ-
ence in the calculated average hydraulic conductivity existed
between samples perfused in the physiological and nonphysi-
ological directions (P  0.001) at statistically equivalent pres-
sures (P  0.46). In addition, the respective flow rates for
A3B perfusions were essentially zero. These results indicate
that the AGs used for the ex vivo model replicated the unidi-
rectional flow of CSF in vivo at normal pressure. These results
agree with our previous in vitro studies using cells cultured
from human AGs,30 and they provide clear evidence in favor of
the traditionally described CSF absorption route at physiologi-
cal pressure.
An assumption made in the calculation of hydraulic conduc-
tivity was that the total perfused AG area was equal to the total
surface area of the perfused tissue. This does not take into
account the morphologic differences between AG samples. It
is possible that AGs have different hydraulic conductivity val-
ues than arachnoid membrane containing microvilli. This sur-
face area assumption led to the calculation of only the baseline,
minimum value of the hydraulic conductivity through the AGs.
An all-inclusive morphologic assessment of each membrane
sample would be required for the calculation of hydraulic
conductivity through AGs compared with arachnoid mem-
brane without visible AGs. This assessment would aid in deter-
TABLE 1. Comparison of Hydraulic Conductivity for AGs Perfused in Physiological (B3A) and








Average A3B 3 6.14  0.23 0.09  0.04 0.11  0.03
Average B3A 20 5.88  0.22 0.76  0.11 1.05  0.15
P — 0.46 0.001 0.001
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mining the total functional transport units associated with fluid
outflow across the human arachnoid membrane and would
allow for comparisons of area available for outflow to smaller
mammals. We have devised a variation of an imaging technique
previously described by our group to quantitatively analyze the
surface area of perfused AGs in arachnoid membrane.
Based on our viability assessment, the working time win-
dow to use AGs after death was narrow, which limited the
number of samples that could be perfused from a single donor.
Efforts were made to collect AG samples from regions corre-
sponding to the lateral lacunae, shown to contain the largest
concentration of AGs.33 Nevertheless, the morphology of every
sample used for experimentation was inherently unique, with
differences in the number of visible AGs and microscopic
arachnoid villi. It has been shown that the AG distribution
varies between donors and is dependent on demographics
such as age, sex, and race.12,31,33 Previous ex vivo animal
studies have studied arachnoid membrane general morphol-
ogy, but techniques to incorporate an AG surface area analysis
were not used, making this a unique addition to our ex vivo
model.
We have successfully used an established imaging tech-
nique to identify total surface area of grossly visible AGs on the
arachnoid membrane, with high reproducibility among inde-
pendent researchers.33 Figure 1 shows a sample image used for
analysis. This technique can directly compare morphologic
differences between tissue donors and can determine the relation-
ship between AG surface area and hydraulic conductivity.
Because of the clinical connection attributed to basal ob-
struction in congenital hydrocephalus, there is great interest in
a new successful model developed in the adult rat. Extraven-
tricular (communicating) obstruction of the basal cisterns in
one group and obstruction of the superior parasagittal sub-
arachnoid space (presumably the AGs) in another group was
achieved using critically placed subarachnoid kaolin.45 In both
groups it was shown that CSF obstruction was obtained and
that communicating ventricular dilatation followed. Of interest
was that basal cistern obstruction produced greater ventricu-
lomegaly and that it did so more quickly than the obstruction
produced by the localized superior suprasagittal kaolin injec-
tions, though they are not fully comparable. Nevertheless, it
verifies that CSF outflow obstruction can be produced by
either technique, confirming that both avenues are operable
and significant in their adult rat model. This work must be
seriously considered in the developmental and clinical aspects
of hydrocephalus in infants.
In conclusion, we have shown and herein demonstrated
that our ex vivo model is feasible. These findings are in agree-
ment with those shown in our earlier in vitro model and with
in vivo CSF outflow physiology. This model will increase our
understanding not only of the clearance of CSF but also of
metabolites through the arachnoid membrane.
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